PG
CNMD icon

PEAK6 Group’s CONMED CNMD Stock Holding History

PEAK6 Group’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$864K Sell
11,800
-1,100
-9% -$74.8K ﹤0.01% 2094
2018
Q1 		$817K Buy
12,900
+10,700
+486% +$639K ﹤0.01% 2142
2017
Q4 		$112K Sell
2,200
-9,300
-81% -$484K ﹤0.01% 3480
2017
Q3 		$603K Buy
11,500
+8,200
+248% +$412K ﹤0.01% 2393
2017
Q2 		$168K Buy
+3,300
New +$163K ﹤0.01% 3504
2017
Q1 		– Sell
-4,500
Closed -$199K – 4386
2016
Q4 		$199K Buy
4,500
+3,200
+246% +$136K ﹤0.01% 3365
2016
Q3 		$52K Sell
1,300
-1,300
-50% -$55.2K ﹤0.01% 3863
2016
Q2 		$124K Sell
2,600
-2,800
-52% -$119K ﹤0.01% 3451
2016
Q1 		$226K Buy
5,400
+1,700
+46% +$66.7K ﹤0.01% 3019
2015
Q4 		$163K Sell
3,700
-1,800
-33% -$78.1K ﹤0.01% 3586
2015
Q3 		$263K Buy
5,500
+3,500
+175% +$192K ﹤0.01% 3486
2015
Q2 		$117K Buy
+2,000
New +$108K ﹤0.01% 4157
2014
Q2 		– Sell
-3,000
Closed -$130K – 4654
2014
Q1 		$130K Buy
+3,000
New +$134K ﹤0.01% 3752

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PEAK6 Group's CNMD Position: Q1 2018 in Review

PEAK6 Group sold out of CONMED (CNMD) in Q1 2018, closing a stake of 761 shares — an estimated $45.4K sold.

PEAK6 Group first reported a position in CNMD in Q1 2014 and held it in 5 quarters. The position peaked at $496K in Q1 2017. 173 funds tracked by Wall St. Rank hold CNMD as of Q1 2018.

  • PEAK6 Group reported no remaining CONMED position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 761 CONMED shares in Q1 2018, an estimated $45.4K.
  • PEAK6 Group first reported a position in CONMED in Q1 2014 and held it in 5 quarters.
  • PEAK6 Group's CONMED position peaked at $496K in Q1 2017.
  • 173 funds tracked by Wall St. Rank held CONMED as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.